At the Society of Clinical Medicine’s 57th Annual Meeting there was a report of a clinical trial using a new molecular imaging agent could improve diagnosis of recurrent prostate cancer. […]
A new phase 3, registration trial has been announced by OncoGenex Pharmaceuticals, Inc. of its investigational drug custirsen sodium (OGX-011/TV-1011). The trial, for men with metastatic castrate resistant prostate cancer (mCRPC) is referred to as the Prostate Cancer SATURN Trial. This randomized, controlled, trial will include approximately 50 cancer centers and is planned to enroll [...]
What are you going to do if you have had radiation therapy as a primary prostate cancer therapy and the cancer has reoccurred? If the disease has remained in the prostate gland some men are able to go back and have surgery, but the condition the gland has been left in post radiation makes it [...]
Researchers, Nelius T, Klatte T, de Riese W, Haynes A, Filleur S. from the Department of Urology, Texas Tech University Health Sciences Center, Lubbock, TX. studied the efficacy of cyclophosphamide (CP)-based metronomic chemotherapy in men who have docetaxel-resistant hormone-refractory prostate cancer (HRPC). […]
I have no clue why this didn't post on Father's day as I set it to. I am marginally annoyed by that. Better late than never, I suppose... I've been writing for this blog for some time now (according to my last post anyway) so I know when it's time for a certain daddy blogger [...]